Spinocerebellar Ataxia 3 (DBCOND0070950)

Identifiers

Synonyms
Machado Joseph Disease / Machado-Joseph Disease / Machado Joseph Disease (SCA3) / Spinocerebellar Ataxias Type 3 / Machado-Joseph Disease Type 3 / Machado-Joseph Disease / Spinocerebellar Ataxia 3 / Spinocerebellar Ataxia Type 3 / Azorean disease (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01096082
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3treatment2 / 3completed
NCT04714307
Neuropsychiatry and Cognition in SCA3/MJDNo drug interventionsNot AvailableNot Availableunknown_status
NCT04419974
Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study AstrocytesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04229823
Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJDNo drug interventionsNot AvailableNot Availableunknown_status
NCT02906046
Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02039206
The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph DiseaseNo drug interventionstreatment2completed
NCT01811706
Dalfampridine and Gait in Spinocerebellar AtaxiastreatmentNot Availablecompleted
NCT04426149
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3No drug interventionstreatmentNot Availablecompleted
NCT03120013
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT03408080
Open Pilot Trial of BHV-4157treatment3active_not_recruiting
NCT03487367
Clinical Trial Readiness for SCA1 and SCA3No drug interventionsNot AvailableNot Availableunknown_status
NCT04153110
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT02175290
Machado-Joseph Disease in IsraelNo drug interventionsNot AvailableNot Availableunknown_status
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordNo drug interventionsNot AvailableNot Availablerecruiting
NCT02147886
Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Diseasetreatment2completed
NCT04268147
Instrumented Data Exchange for Ataxia StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05826171
Priming Motor Learning Through Exercise in People With Spinocerebellar AtaxiaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05502432
Repetitive Transcranial Magnetic Stimulation in SCA3 PatientsNo drug interventionstreatmentNot Availablecompleted
NCT03701399
Troriluzole in Adult Subjects With Spinocerebellar Ataxiatreatment3active_not_recruiting
NCT05490563
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar AtaxiaNo drug interventionstreatment2 / 3terminated
NCT05557786
Treatment of Transcranial Alternating Current Stimulation(tACS)on Cerebellar AtaxiaNo drug interventionstreatmentNot Availablecompleted
NCT04399265
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3No drug interventionstreatmentNot Availableunknown_status
NCT03885167
Identification of Biomarkers in Spinocerebellar Ataxia 3No drug interventionsNot AvailableNot Availablecompleted
NCT05822908
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HDtreatment1 / 2recruiting
NCT04301284
Study of CAD-1883 for Spinocerebellar Ataxiatreatment2withdrawn
NCT01060371
Natural History Study of and Genetic Modifiers in Spinocerebellar AtaxiasNo drug interventionsNot AvailableNot Availablerecruiting
NCT00992771
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3treatment2completed
NCT05160558
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3No drug interventionstreatment1terminated
NCT01096095
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3treatment2withdrawn
NCT03378414
Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar AtaxiaNo drug interventionstreatment2not_yet_recruiting